Cargando…
GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity
Ovarian cancer is the most lethal of the gynecologic malignancies. N-acetylgalactosaminyltransferase 6 (GALNT6), an enzyme that mediates the initial step of mucin type-O glycosylation, has been reported to regulate mammary carcinogenesis. However, the expression and role of GALNT6 in ovarian cancer...
Autores principales: | Lin, Tzu-Chi, Chen, Syue-Ting, Huang, Min-Chuan, Huang, John, Hsu, Chia-Lang, Juan, Hsueh-Fen, Lin, Ho-Hsiung, Chen, Chi-Hau |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522090/ https://www.ncbi.nlm.nih.gov/pubmed/28388560 http://dx.doi.org/10.18632/oncotarget.16585 |
Ejemplares similares
-
Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling
por: Huang, Miao-Juei, et al.
Publicado: (2015) -
GALNT2 promotes invasiveness of colorectal cancer cells partly through AXL
por: Liao, Ying‐Yu, et al.
Publicado: (2022) -
Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation
por: Liu, Shin-Yun, et al.
Publicado: (2016) -
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer
por: Lee, Po-Chu, et al.
Publicado: (2020) -
GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma
por: Ho, Wan-Ling, et al.
Publicado: (2014)